41 results on '"Grossegesse, Marica"'
Search Results
2. A bead-based multiplex assay covering all coronaviruses pathogenic for humans for sensitive and specific surveillance of SARS-CoV-2 humoral immunity
3. Evaluation of a commercial ELISA as alternative to plaque reduction neutralization test to detect neutralizing antibodies against SARS-CoV-2
4. Longitudinal SARS-CoV-2 seroepidemiological investigation among healthcare workers at a tertiary care hospital in Germany
5. Mpox-Specific Immune Responses Elicited by Vaccination or Infection in People With HIV
6. Seroprevalence of anti-SARS-CoV-2 antibodies and risk of viral exposure among healthcare workers in the South Kivu province, eastern Democratic Republic of the Congo: a cross-sectional study
7. Serological methods for the detection of antibodies against monkeypox virus applicable for laboratories with different biosafety levels
8. Resource-efficient internally controlled in-house real-time PCR detection of SARS-CoV-2
9. Follow-up SARS-CoV-2 serological study of a health care worker cohort following COVID-19 booster vaccination.
10. Impact of ACE I gene insertion/deletion, A-240T polymorphisms and the renin–angiotensin–aldosterone system on COVID-19 disease.
11. Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity
12. Vaccine effectiveness against severe COVID-19 during the Omicron wave in Germany: Results from the COViK study
13. Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022
14. Analysis of two choir outbreaks acting in concert to characterize long- range transmission risks through SARS-CoV-2, Berlin, Germany, 2020
15. Analysis of two choir outbreaks acting in concert to characterize long- range transmission risks through SARS-CoV-2, Berlin, Germany, 2020
16. Multicountry study of SARS-CoV-2 and associated risk factors among healthcare workers in Côte d'Ivoire, Burkina Faso and South Africa
17. Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022
18. Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany—Results from the SeBluCo Study 2020–2022.
19. Multicountry study of SARS-CoV-2 and associated risk factors among healthcare workers in Côte d'Ivoire, Burkina Faso and South Africa.
20. Additional file 1 of Longitudinal SARS-CoV-2 seroepidemiological investigation among healthcare workers at a tertiary care hospital in Germany
21. Deep Time Course Proteomics of SARS-CoV- and SARS-CoV-2-Infected Human Lung Epithelial Cells (Calu-3) Reveals Strong Induction of Interferon-Stimulated Gene Expression by SARS-CoV-2 in Contrast to SARS-CoV
22. Establishment of a specimen panel for the decentralised technical evaluation of the sensitivity of 31 rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021
23. Analysis of Two Choir Outbreaks in Germany in 2020 Characterizes Long- range Transmission Risks Through SARS-CoV-2
24. Analysis of SARS-CoV-2 RNA Stability and Infectivity in Oropharyngeal Swab Samples
25. Detection of neutralizing antibodies against SARS-CoV-2 by using a commercial surrogate virus neutralization ELISA: can it substitute the classical neutralization test?
26. Decision letter: Rapid and sensitive detection of SARS-CoV-2 infection using quantitative peptide enrichment LC-MS analysis
27. Inactivation of Coronaviruses during Sample Preparation for Proteomics Experiments
28. Establishment of an evaluation panel for the decentralized technical evaluation of the sensitivity of 31 rapid detection tests for SARS-CoV-2 diagnostics
29. Additional file 1 of Resource-efficient internally controlled in-house real-time PCR detection of SARS-CoV-2
30. Deep time course proteomics of SARS-CoV- and SARS-CoV-2-infected human lung epithelial cells (Calu-3) reveals strong induction of interferon-stimulated gene (ISG) expression by SARS-CoV-2 in contrast to SARS-CoV
31. Application of spectral library prediction for parallel reaction monitoring of viral peptides
32. Amantadine Inhibits SARS-CoV-2 In Vitro
33. Perspective on Proteomics for Virus Detection in Clinical Samples
34. Stable Isotope-Triggered Offset Fragmentation Allows Massively Multiplexed Target Profiling on Quadrupole-Orbitrap Mass Spectrometers
35. Aufklärung orthopockenviraler Adaptionsmechanismen mittels Proteomik und Genomik
36. Purple: A Computational Workflow for Strategic Selection of Peptides for Viral Diagnostics Using MS-Based Targeted Proteomics
37. Global ubiquitination analysis reveals extensive modification and proteasomal degradation of cowpox virus proteins, but preservation of viral cores
38. DMSO as a mobile phase additive enhances detection of ubiquitination sites by nano-LC-ESI-MS/MS
39. Combined Proteomics/Genomics Approach Reveals Proteomic Changes of Mature Virions as a Novel Poxvirus Adaptation Mechanism
40. A Next-Generation Sequencing Approach Uncovers Viral Transcripts Incorporated in Poxvirus Virions
41. Mpox-specific immune responses elicited by vaccination or infection in people living with HIV.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.